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A peroxidase with stability, chromatographic and immunoreactive properties imilar to that of bovine lacto- 
peroxidase has been partly purified from human colostrum. Hydrophobic interaction chromatography on 
~enyl-~pharo~ Cl-4B gave a lo-fold puri~cation with an apparent recovery of about 45%. The enzyme 
was quantitatively and specifically adsorbed to beads of any-lacto~roxid~e (bo~ne~protein A-Sepharose. 
No adsorption of the enzyme was observed on immunoadsor~nt columns prepared with high-titre poly- 
clonal antibodies raised against human myeloperoxidase and human eosinophile peroxidase. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Human breast milk contains many enzymes, 
some of which may assist in digestion or have other 
functions [l]. Particular interest has been focused 
on the possible presence of a lactoperoxidase anti- 
microbial system in human milk as an important 
factor in the defence against infections (review 
[2-41). However, no true secretory peroxidase has 
so far been isolated from human milk, and the 
question of whether human milk contains a secre- 
tory peroxidase as proposed [5], or if the activity 
can be accounted for by myeloperoxidase present 
in neutrophile granulo~~es, isnot yet answered. In 
a recent biochemical study it was concluded that 
there is no detectable lactoperoxidase in human 
milk, and that the peroxidase activity found in 
human colostrum is attributed to myeloperoxidase 
derived from leukocytes in the milk [6]. Here, we 
report on the demonstration and partial purifica- 
tion of a peroxidase from human colostrum, which 
has a stability as well as chromatographic and im- 
munoreactive properties similar to that of lacto- 
peroxidase isolated from bovine milk 171. 
2.1. Preparation of human colostrum and 
leukocytes 
Samples of human colostrum, obtained from 4 
healthy mothers 2-4 days after delivery, were 
pooled and kept frozen at -25’C until used. Fat 
was removed by centrifugation at 38000 x g for 
45 min at 4V.I. Casein was partly removed by ad- 
justing the pH to 4.6 [8], followed by precipitation 
for 1 h at 0°C and centrifugation at 38000 x g for 
45 min at 4°C. The pH of the resulting whey was 
adjusted to 7.0, and concentrated Na-acetate was 
added to match the buffer (2 M Na-acetate, pH 7.0) 
used to equilibrate the Phenyl-Sepharose column 
(see section 2.2), 
Leukocytes were prepared from blood of healthy 
donors 191. 
2.2. Chromatography on Phenyl-Sepharose 
Hydrophobic interaction chromatography on a 
column (2 x 10cm) of Phenyl-Sepharose Cl-4B 
(Pharmacia, Uppsala) was performed essentially as 
described for bovine lactoperoxidase IlO], including 
equilibration of the column with 2 M Na-acetate, 
pH 7.0. The whey was centrifuged (12000 x g for 
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20min at 4°C) and adsorbed at a flow rate of 
0.05 ml/min, and the column washed with equili- 
bration buffer. Isocratic elution was obtained with 
0.05 M Na-acetate, pH 7.0, at a flow rate of 
0.05 ml/min. The collected fractions (1.5 ml each) 
were analyzed for absorbance at 280 and 412 nm 
and peroxidase activity. The overall preparation 
time was 48 h. 
2.3. Isolation df peroxidases 
Bovine lactoperoxidase B was isolated essen- 
tially as described [7]. Human myeloperoxidase 
[ 1 l] and eosinophile peroxidase [ 1 l] were isolated 
as described, and generously supplied by Dr. 
Ragnar L. Olsen, Institute of Medical Biochemistry, 
University of Tromss. The specific activities were 
8.9, 15.2, and 50.8 U/mg protein for the purified 
lactoperoxidase, myeloperoxidase and eosinophile 
peroxidase, respectively. 
2.4. Polyclonal antibodies 
Polyclonal antibodies were raised in rabbits 
against bovine lactoperoxidase B by a standard im- 
munization protocol. The immune-serum was used 
either without further purification or after purifi- 
cation by ammonium sulfate fractionation [12]; 
the partly purified IgG fraction was stored at 
-25’C at a concentration of 5.2 mg/ml (IgG) in 
5 mM K-phosphate (pH 7.0) and 50 mM NaCl. 
13.788 IgG completely removed 1 fig of bovine lac- 
toperoxidase B. Polyclonal antibodies against 
human myeloperoxidase and human eosinophile 
peroxidase were generously supplied by Dr. Ragnar 
L. Olsen, Institute of Medical Biology, University 
of Tromso. The anti-myeloperoxidase was purified 
by affinity chromatography on a myeloperoxidase- 
Sepharose column, and stored at a concentration 
of 0.3 1 mg/ml in 50 mM Tris (pH 7.4) and 0.15 M 
NaCl; 6/cg of the purified IgG completely removed 
the activity of lpg myeloperoxidase. The anti- 
eosinophile peroxidase was purified by fractional 
ammonium sulphate precipitation and DEAE- 
cellulose chromatography, and stored at a concen- 
tration of 1 .O mg/ml in 50 mM Tris (pH 7.4) and 
0.15 M NaCl; 6,ug of the purified IgG completely 
removed the activity of lpg eosinophile peroxi- 
dase. 
2.5. Protein A-Sepharose immunoaffinitycolumns 
Protein A-Sepharose (Pharmacia) was swollen 
in 100mM K-phosphate buffer, pH 8.0. For each 
adsorption experiment approx. 50~1 of swollen gel 
(equivalent o 15 mg dry wt) was preincubated with 
serum or purified IgG diluted in equilibration buf- 
fer, pH 8.0; 60-54Opg IgG in a total volume of 
400~1 was used in each experiment. The suspension 
was gently stirred by a micropipette for 1 h at 0°C. 
After washing with the equilibration buffer (20 bed 
volumes x 5), the Sepharose beads were suspended 
in 120~1 of 100 mM K-phosphate buffer, pH 7.4, 
to which 60~1 of the antigen was added. The sus- 
pension was gently stirred by a micropipette for 1 h 
at 0°C (approx. 15 times), and the supernatant 
above the sedimented Sepharose beads was assayed 
for peroxidase activity. In experiments with highly 
purified peroxidases, the enzymes were diluted in 
media containing either unspecific milk proteins or 
bovine serum albumin. 
2.6. Peroxidase activity 
Peroxidase activity was measured at 470 nm by 
the guaiacol method [ 131 using a Cary model 219 
spectrophotometer and the extinction coefficient E 
(mM_’ *cm-‘) = 26.6 for tetraguaiacol at 470 nm 
[ 141. One unit of activity is defined as 1 pmol tetra- 
guaiacol formed per min at 25°C. 
2.7. Other analytical procedures 
Protein was measured by the Coomassie brilliant 
blue method [ 151. Bovine lactoperoxidase B was 
assayed spectrophotometrically using the extinc- 
tion coefficient 6 (mM_’ *cm-‘) = 112.2 at 412 nm 
1161. 
3. RESULTS 
3. I. Peroxidase activity in human colostrum 
In agreement with [5] we found that the peroxi- 
dase activity of freshly obtained colostrum varies 
greatly between donors, i.e., from almost zero to 
12.6mU/ml of skimmed milk in which the total 
peroxidase activity was removed by an immuno- 
affinity column of anti-lactoperoxidase (bovine) 
(see sections 2.5 and 3.3). 
3.2. Chromatography on Phenyl-Sepharose CL-4B 
When 90 ml of pooled whey of human colostrum 
(see section 2.2), containing 153 mU peroxidase, 
was subjected to hydrophobic affinity chromato- 
graphy on Phenyl-Sepharose Cl-4B, the total per- 
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oxidase activity was adsorbed to the column. A 
peak of absorbance at 412nm and peroxidase 
activity was eluted (fig.1) under conditions and 
with a retention time characteristic of bovine lacto- 
peroxidase [lo]. The elution profile at 412 nm re- 
vealed a major peak corresponding to the peak of 
peroxidase activity (21 .O mu/ml in the peak frac- 
tion), but additional components with absorbance 
at 412 nm were also observed with retention times 
shorter than the peroxidase; the absorption spectra 
indicated the possible presence of flavoproteins 
(not shown). Additional milk proteins eluted with 
the peroxidase activity as indicated by the &son,,, 
absorbance profile (fig. 1). 
It should be mentioned that the peroxidase in 
human colostrum also binds to the lectin column 
ConA-Sepharose, and is eluted from this column 
in a manner similar to that observed for bovine lac- 
toperoxidase (not shown). Furthermore, when a 
crude preparation of approx. 740 mU of myeloper- 
oxidase, extracted from human leucocytes, was 
processed as described in section 2.2 and chro- 
matographed on Phenyl-Sepharose, no activity 
was recovered in the eluted material. 
3.3. Immunological studies 
The fractions collected from the Phenyl-Sepha- 
rose Cl-4B column containing the highest peroxi- 
dase activity were used for the immunoadsorption 
experiments. As seen from fig.2, 0.3-2.4 mU of 
the isolated peroxidase (i.e., the peak fraction in 
fig.1) was found to be quantitatively adsorbed to 
the anti-lactoperoxidase (bovine)-Protein A- 
Sepharose beads at an antibody: antigen ratio (by 
weight) of 2000: 1 or higher. No adsorption of the 
enzyme was obtained with the corresponding pre- 
immune serum or with the polyclonal antibodies 
raised against human myeloperoxidase (the total 
binding capacity of the immunoadsorbent was 
estimated to be lO.Opg or 152 mU of specific 
peroxidase) or human eosinophile peroxidase (the 
total binding capacity of the immunoadsorbent 
was estimated to be 16.7pg or 848 mU of specific 
peroxidase). 
In order to further test the specificity of our 
polyclonal antibodies against bovine lactoperoxi- 
dase, adsorption experiments with highly purified 
human myeloperoxidase and human eosinophile 
peroxidase were also performed; the purified en- 
zymes were stabilized by added unspecific milk 
proteins (see section 2.5). None of the eosinophile 
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Fig.1. Elution profile of lactoperoxidase from human 
colostrum on Phenyl-Sepharose Cl-4B chromatography. 
The absorbance at 280 (A) and 412 (0) nm as well as 
peroxidase activity (0) were measured in each fraction. 
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Fig.2. Immunoadsorption f partly purified lactoper- 
oxidase from human colostrum to beads of Protein 
A-Sepharose (A) prepared with anti-lactoperoxidase 
(bovine) immune serum (IS) or with preimmune serum 
(PIS). Controls with purified human myeloperoxidase 
(0) and purified human eosinophile peroxidase (0). 
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peroxidase (O.lOpg or 5.0 mU of enzyme and an 
antibody : antigen ratio (by wt) of 5400 : 1) was ad- 
sorbed to the beads of anti-lactoperoxidase (bo- 
vine)-protein A-Sepharose, whereas the myeloper- 
oxidase (0.38pg or 5.8mU of enzyme) was 
adsorbed to about 20% (18-22070, n = 6) at an 
antibody: antigen ratio (by weight) of 1420: 1. 
4. DISCUSSION 
Peroxidase activity was first demonstrated in 
human milk by authors in [5]. Based on stability 
studies of the enzyme it was concluded that the 
peroxidase was similar to bovine lactoperoxidase 
and therefore represented a genuine secretory per- 
oxidase, and possibly also an important defence 
factor in human milk. This conclusion has more 
recently been challenged by biochemical studies [6] 
concluding that there is no detectable lactoperoxi- 
dase in human milk, and that the peroxidase 
activity often found in human colostrum is due to 
peroxidase derived from milk leukocytes. 
Here, both chromatographic and immunologic 
experiments upport the presence of a true secre- 
tory peroxidase (lactoperoxidase) in human colos- 
trum. The chromatographic behaviour of the per- 
oxidase on Phenyl-Sepharose Cl-4B, as determined 
by the absorbance at 412 nm and peroxidase activity 
(fig.l), was similar to that of bovine lactoperoxi- 
dase [lo], and we have also reached a similar con- 
clusion based on affinity chromatography on a lec- 
tin column of ConA-Sepharose (data not shown), 
indicating that the human milk peroxidase is a 
glycoprotein, as is the bovine enzyme [7]. It should 
also be mentioned that the enzyme is quite stable, 
including exposure to both low pH (4.6) and high 
ionic strength (2 M Na-acetate). These conditions 
result in a rapid decay of myeloperoxidase when 
added to skimmed milk preparations at concentra- 
tions about 5 times higher than corresponding to 
the endogeneous peroxidase activity in the colos- 
trum (not shown). Most significant, however, was 
the finding that the isolated peroxidase from 
human milk reacts with anti-lactoperoxidase (bo- 
vine), but not with anti-myeloperoxidase (human) 
and anti-eosinophile peroxidase (human) (fig.2). 
The recovery (45% based on activity measure- 
ments) of 67 mU peroxidase (equivalent to 7.5pg 
bovine lactoperoxidase) from 90 ml of pooled 
colostrum explains why this peroxidase has re- 
mained undetected for so long, and particularly 
the negative conclusions of authors in [6] who 
based their immunological studies on immuno- 
diffusion experiments only. Although our results 
have shown that human milk peroxidase activity is 
due to a true secretory peroxidase (lactoperoxi- 
dase), further studies on the purified enzyme will 
be required to demonstrate its chemical properties. 
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